Dual PARP/Tankyrase Inhibition Enhances Antitumor Efficacy in PTEN-Deficient Endometrial Cancer. - Kang SW; Eum H; Lee JY; Lee MS; Kim YM; Kim TW; Lee SW (Journal of cellular and molecular medicine, 2026)